Prot# NU 04H6: A Phase II Trial of Alemtuzumab (Campath-1H) and Rituximab (Rituxan) in Patients with Previously Untreated CLL

Project: Research project

Project Details

StatusFinished
Effective start/end date3/11/058/31/10

Funding

  • Bayer HealthCare Pharmaceuticals, Inc. (NU 04H6)